|
|
|
|
|
|
|
Poster: 157
Visits: 124
Title: Prognostic impact of cell of origin profile in young patients with high risk diffuse large B cell lymphoma: results of the BIO-DLCL04 trial of Fondazione Italiana Linfomi
Authors: ANNALISA CHIAPPELLA , Agostinelli C, Martelli M, Righi S, Evangelista A, Novero D, Gotti M, Carella AM, Stelitano C, Rossi G, Angelucci E, Balzarotti M, Gaidano G, Ladetto M, Pileri SA and Vitolo U.
Centre: On behalf of Fondazione Italiana Linfomi
|
|
You must be registered to reply or comment.
|
|
PROGNOSTIC IMPACT OF CELL OF ORIGIN PROFILE IN YOUNG PATIENTS WITH HIGH RISK DIFFUSE LARGE B CELL LYMPHOMA: RESULTS OF THE BIO-DLCL04 TRIAL OF FONDAZIONE ITALIANA LINFOMI
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology
|
|
|
|